Brownstein Hyatt Farber Schreck LLP Obo Romark Global Pharma, LLC
Pharmaceutical product distributor
Based in PR
AI Overview
With $0 in lobbying spend across 4 quarterly filings, Brownstein Hyatt Farber Schreck LLP Obo Romark Global Pharma, LLC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $0 |
| 2023 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Brownstein Hyatt Farber Schreck LLP Obo Romark Global Pharma, LLC disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy
Issues regarding funding for the Biomedical Advanced Research and Development Authority
Issues regarding funding for the Biomedical Advanced Research and Development Authority.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.